Drug application
BACITRACIN ZINC AND POLYMYXIN B SULFATE (BACITRACIN ZINC, POLYMYXIN B SULFATE)
Drugs@FDA ANDA 065022 · PADAGIS US
Key facts
| Drug name | BACITRACIN ZINC AND POLYMYXIN B SULFATE |
|---|---|
| Active ingredients | BACITRACIN ZINC, POLYMYXIN B SULFATE |
| Application type | ANDA |
| Application number | 065022 |
| Company | PADAGIS US |
| Dosage forms | OINTMENT, OPHTHALMIC |
| Strength | 500 UNITS/GM;10,000 UNITS/GM |
| Marketing status | Discontinued |
| TE codes | AT |
| Reference listed drug | No |
| Latest submission status date | Feb 27, 2002 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.